SCIENTURE HOLDINGS, INC. Repayments of Short-term Debt
SCIENTURE HOLDINGS, INC. (SCNX) reported Repayments of Short-term Debt of $150.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2025-03-26
- SCIENTURE HOLDINGS, INC. repayments of short-term debt for the quarter ending 2018-12-31 was $100.99K.
- SCIENTURE HOLDINGS, INC. repayments of short-term debt for the quarter ending 2018-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. repayments of short-term debt for the quarter ending 2018-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. repayments of short-term debt for the quarter ending 2018-03-31 was $10.74K.
- SCIENTURE HOLDINGS, INC. repayments of short-term debt for fiscal 2023 was $150.00K.
- SCIENTURE HOLDINGS, INC. repayments of short-term debt for fiscal 2019 was $262.55K, a 135.00% increase from fiscal 2018.
- SCIENTURE HOLDINGS, INC. repayments of short-term debt for fiscal 2018 was $111.72K.
- SCIENTURE HOLDINGS, INC. repayments of short-term debt for fiscal 2015 was $0.00.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $150.00K 10-K · filed 2025-03-26 | |||
| 2019-12-31 | $262.55K 10-K · filed 2020-03-30 | |||
| 2018-12-31 | $100.99K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $100.99K derived: sum of 2 quarters · filed 2020-03-30 | $100.99K derived: sum of 3 quarters · filed 2020-03-30 | $111.72K 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $0.00 derived: sum of 2 quarters · filed 2019-10-28 | $10.74K 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $10.74K 10-Q · filed 2019-07-26 | ||
| 2018-03-31 | $10.74K 10-Q · filed 2019-05-13 | |||
| 2016-06-30 | -$50.00K 10-Q · filed 2016-08-05 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-03-28 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-05 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$10.00K 10-K · filed 2016-03-28 | ||
| 2014-09-30 | -$10.00K 10-Q · filed 2014-10-30 | |||
| 2013-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | -$50.00K 10-K · filed 2015-03-23 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |